Insulin pumps are the devices used to administer insulin in the body to control the diabetes. The global insulin pumps and accessories market is broadly segmented into insulin pumps, infusion sets, insulin reservoirs/cartridges, infusion set insertion devices, and others.
The pivotal factors driving the growth of this market are increasing prevalence of diabetes, development of various types of insulin, and growing awareness towards diabetes and insulin delivering devices. In addition, development of artificial pancreas and home infusion therapy is further promoting the growth of this market to a certain extent. Moreover, professional and consumer information programs provided by insulin infusion pump manufacturers are encouraging adoption of insulin delivering devices and ultimately driving the growth of this market. However, various concerns associated with insulin delivering devices such as skin infections and high cost of the insulin analogs and pumps are hampering the growth of this market. In addition, lack of skilled professional for appropriate handling of insulin pump further restrains the growth of this market to a certain extent. Moreover, currently, research on aerosolized insulin for inhalation, oral insulin, and insulin-producing stem cell implantation is going on and positive result will lead to hamper the growth of this market.
Geographically, North America is the largest market for global insulin pump and accessories market, with the U.S. contributing a major share, followed by Europe, Asia-Pacific, and the Rest of the World. North America and Europe will continue to dominate the market during the forecast period owing to the growing number of diabetic patients and technological advancement in insulin pump. However, a majority of the growth in the insulin pump and accessories market is expected to be from emerging markets in the Asia-Pacific, owing to the growing number of diabetes patients and increasing awareness towards glycemic control and advance insulin delivery devices in these regions.
Major market players in the global insulin pump and accessories market are Animus Corporation (U.S.), Asante (U.S.), Cellnovo Ltd. (U.K.), Insulet Corporation (U.S.), Medtronics, Inc. (U.S.), Nipro Diagnostic, Inc. (Japan), Ypsomed (Switzerland), Roche (Switzerland), Sooil Development Co., Ltd. (Korea), and Tandem Diabetes Care, Inc. (U.S.).
Scope of the Report-
Insulin infusion devices such as insulin pumps, infusion sets, insulin reservoirs/cartridges, Infusion set insertion devices etc. are used to deliver the insulin for glycemic control in diabetic patients. In insulin requiring diabetic condition, these devices are used to administer insulin. Insulin pump therapy is considered as the “gold standard” of therapy for the diabetes patients.
Global Insulin Infusion Pump Market
This research report categorizes the Insulin Infusion Pump and Accessories market into the following segments:
Insulin Infusion Pump and Accessories Market, by Product
Benchmarking the rapid strategy shifts of the Top 100 companies in the Insulin Pump MarketRequest For Special Pricing